LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.19 Cr | ₹-10 Cr | ₹6.26 Cr | ₹1.27 Cr | ₹2.15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LASA SUPERGENERICS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-0.19 Cr |
Mar2023 | ₹-10 Cr |
Mar2022 | ₹6.26 Cr |
Mar2021 | ₹1.27 Cr |
Mar2020 | ₹2.15 Cr |
How is Net Cash Inflow / Outflow of LASA SUPERGENERICS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-0.19 Cr | Negative | |
Mar2023 | ₹-10 Cr | Negative | |
Mar2022 | ₹6.26 Cr | 392.83 | |
Mar2021 | ₹1.27 Cr | -40.88 | |
Mar2020 | ₹2.15 Cr | - |
Compare Net Cash Inflow / Outflow of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹130.1 Cr | 0.7% | -10.4% | -19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | 0.7% |
-10.4% |
-19.2% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses